Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRA + High-dose Dexamethasone for Initial ITP
NCT01882127Phase 3Withdrawn
- Sponsor
- Shandong University
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tretinoin in immune thrombocytopenia (ITP), sponsored by Shandong University. Planned start Feb 2013; status: withdrawn.
02
Drugs
tretinoin
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT01882127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01882127.